New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Merck & Co., Inc.

MRK

Healthcare Drug Manufacturers General

Merck & Co., Inc.’s revenue for fiscal 2025 (year ended December 2025) was $65.0 billion, up 1.31% from fiscal 2024.

Revenue
+4.68%
EPS
−12.1%
Free cash flow
−19.3%
Total debt
+24.3%

Quarter to September 2026, against a year earlier

134.96 2.22 +1.67%
Market cap
$328.6B
P/E
137×
Fwd P/E FY26e
105×
Dividend yield
2.56%
F-score
4/9
ROIC
4.56%
Net debt / EBITDA
1.2×
Payout ratio
3.5×

Merck & Co., Inc. (MRK) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
8-K Nov 16, 2026 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits Officer departure
10-Q Sep 30, 2026 P1I2: 10 added · 8 removed · 79 modified
P2I1A: no comparison — the Item was not found
8-K Oct 29, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Oct 9, 2026 5.02 Departure or appointment of directors or officers
10-Q Jun 30, 2026 P1I2: 25 added · 6 removed · 71 modified
P2I1A: no comparison — the Item was not found
8-K Aug 4, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K May 26, 2026 5.07 Submission of matters to a vote of security holders
8-K May 22, 2026 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Mar 31, 2026 P1I2: 27 added · 44 removed · 68 modified
P2I1A: no comparison — the Item was not found
8-K Apr 30, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Dec 31, 2025 1: 45 added · 38 removed · 89 modified
1A: 10 added · 3 removed · 60 modified
7: 62 added · 54 removed · 119 modified
8-K Feb 3, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Dec 4, 2025 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Sep 30, 2025 P1I2: 26 added · 8 removed · 57 modified
P2I1A: no comparison — the Item was not found
8-K Oct 30, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Sep 9, 2025 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Jun 30, 2025 P1I2: 22 added · 5 removed · 65 modified
P2I1A: no comparison — the Item was not found
8-K Jul 25, 2025 2.02 Results of operations and financial condition; 2.05 Costs of exit or disposal activities; 9.01 Financial statements and exhibits
10-Q Mar 31, 2025 P1I2: no comparison — the earlier filing's text is no longer kept
P2I1A: no comparison — the Item was not found
8-K Apr 24, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Dec 31, 2024 1: no comparison — no earlier filing on file
1A: no comparison — no earlier filing on file
7: no comparison — no earlier filing on file
8-K Feb 4, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Sep 30, 2024
8-K Oct 31, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2024
8-K Jul 30, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Apr 25, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jan 29, 2024 2.02 Results of operations and financial condition; 2.05 Costs of exit or disposal activities; 9.01 Financial statements and exhibits

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.